Evaluating serum galectin-3 binding protein as a diagnostic and prognostic biomarker in pulmonary arterial hypertension: a comparative study
Published: December 30 2024
Abstract Views: 1349
PDF: 355
HTML: 0
HTML: 0
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Background: Pulmonary arterial hypertension (PAH) is a severe condition with poor prognosis, characterized by elevated pulmonary artery pressure that leads to right ventricular failure. Identifying reliable biomarkers, such as Galectin-3 Binding Protein (Gal-3BP), could enhance PAH diagnosis and prognosis due to Gal-3BP's involvement in inflammation and fibrosis.
Methods: This prospective cohort study included 260 participants, 130 diagnosed with PAH and 130 healthy controls, from a tertiary care center. Serum Gal-3BP, NT-proBNP, and other biomarkers were measured alongside regular cardiopulmonary assessments. Right heart catheterization assessed hemodynamic parameters, and survival was analyzed using Kaplan-Meier curves over a 2-year period.
Results: PAH patients exhibited significantly higher serum Gal-3BP levels (5.34 ± 2.45 μg/mL) than controls (2.15 ± 0.95 μg/mL, p<0.001), correlating with elevated pulmonary artery pressure and reduced cardiac output (p<0.001). Kaplan-Meier analysis indicated lower survival rates for patients with Gal-3BP levels above the median (p<0.0001). Female patients averaged 58 years, with a 69% female study population.
Conclusions: Gal-3BP is significantly elevated in PAH patients, correlating with disease severity and predicting survival, positioning it as a promising biomarker for PAH diagnosis and prognosis. Future studies should examine Gal-3BP's role in therapeutic response and refine its clinical application.
Altmetrics
Downloads
Download data is not yet available.
Citations
1. Li M, Pan W, Tian D, et al. Diagnostic value of serum galectin-3 binding protein level in patients with pulmonary arterial hypertension. Curr Vasc Pharmacol 2024;22:67-77. DOI: https://doi.org/10.2174/0115701611268078231010072521
2. Haigh S, Bordán Z, Sellers HG, et al. Galectin 3 secretion in pulmonary arterial hypertension. Physiology 2023;38:5732582. DOI: https://doi.org/10.1152/physiol.2023.38.S1.5732582
3. Sun Y-Y, Wang L, Liu J-M, Yuan P. Reply to Sun et al.: circGASP: a new clinical biomarker for idiopathic pulmonary hypertension? Am J Respir Crit Care Med 2022;205:254. DOI: https://doi.org/10.1164/rccm.202108-1905LE
4. Jain A. High circulating plasma soluble receptor for advanced glycation end-products in early COVID-19-associated acute respiratory distress syndrome: pathophysiological significance? Am J Respir Crit Care Med 2022;205:254-6. DOI: https://doi.org/10.1164/rccm.202108-1896LE
5. Bouzina H, Hesselstrand R, Rådegran G. Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension. Pulm Circ 2019;9:2045894019895446. DOI: https://doi.org/10.1177/2045894019895446
6. Tifi P, Pala B, Tempestini F, et al. 729 Biomarkers for early diagnosis of cardiac involvement in systemic sclerosis. Eur Heart J Suppl 2022;24:suac121-284. DOI: https://doi.org/10.1093/eurheartjsupp/suac121.284
7. Kostyunina DS, Pakhomov NV, Jouida A, et al. Transcriptomics and proteomics revealed sex differences in human pulmonary microvascular endothelial cells. Physiol Genomics 2024;56:194-220. DOI: https://doi.org/10.1152/physiolgenomics.00051.2023
8. Chida A, Sato H, Shintani M, et al. Soluble ST2 and N-terminal pro-brain natriuretic peptide combination - useful biomarker for predicting outcome of childhood pulmonary arterial hypertension. Circ J 2014;78:436-42. DOI: https://doi.org/10.1253/circj.CJ-13-1033
9. de Boer RA, Yu L, van Veldhuisen DJ. Galectin-3 in cardiac remodeling and heart failure. Curr Heart Fail Rep 2010;7:1-8. Erratum in Curr Heart Fail Rep 2012;9:163. DOI: https://doi.org/10.1007/s11897-010-0004-x
10. Mocumbi AO, Thienemann F, Sliwa K. A global perspective on the epidemiology of pulmonary hypertension. Can J Cardiol 2015;31:375-81. DOI: https://doi.org/10.1016/j.cjca.2015.01.030
11. Hemnes A, Rothman AMK, Swift AJ, Zisman LS. Role of biomarkers in evaluation, treatment and clinical studies of pulmonary arterial hypertension. Pulm Circ 2020;10;2045894020957234. DOI: https://doi.org/10.1177/2045894020957234
12. Carrigan P, Krahn T. Impact of biomarkers on personalized medicine. Handb Exp Pharmacol 2016;232:285-311. DOI: https://doi.org/10.1007/164_2015_24
13. Al-Naamani N, Palevsky HI, Lederer DJ, et al. Prognostic significance of biomarkers in pulmonary arterial hypertension. Ann Am Thorac Soc 2016;13:25-30. DOI: https://doi.org/10.1513/AnnalsATS.201508-543OC
14. Giansanti F, Capone E, Ponziani S, et al. Secreted Gal-3BP is a novel promising target for non-internalizing antibody-drug conjugates. J Control Release 2019;294:176-84. DOI: https://doi.org/10.1016/j.jconrel.2018.12.018
15. Gleissner CA, Erbel C, Linden F, et al. Galectin-3 binding protein, coronary artery disease and cardiovascular mortality: Insights from the LURIC study. Atherosclerosis 2017;260:121-9. DOI: https://doi.org/10.1016/j.atherosclerosis.2017.03.031
16. Lima T, Perpétuo L, Henrique R, et al. Galectin-3 in prostate cancer and heart diseases: a biomarker for these two frightening pathologies? Mol Biol Rep 2023;50:2763-78. DOI: https://doi.org/10.1007/s11033-022-08207-1
17. Cibor D, Szczeklik K, Brzozowski B, et al. Serum galectin 3, galectin 9 and galectin 3-binding proteins in patients with active and inactive inflammatory bowel disease. J Physiol Pharmacol 2019;70:95-104. DOI: https://doi.org/10.1093/ecco-jcc/jjy222.146
18. Rosenkranz S, Preston IR. Right heart catheterisation: best practice and pitfalls in pulmonary hypertension. Eur Respir Rev 2015;24:642-52. DOI: https://doi.org/10.1183/16000617.0062-2015
19. Razmjou S, Abdulnour J, Bastard JP, et al. Body composition, cardiometabolic risk factors, physical activity, and inflammatory markers in premenopausal women after a 10-year follow-up: a MONET study. Menopause 2018;25:89-97. DOI: https://doi.org/10.1097/GME.0000000000000951
20. Ramirez MF, Honigberg M, Wang D, et al. Protein biomarkers of early menopause and incident cardiovascular disease. J Am Heart Assoc 2023;12:e028849. DOI: https://doi.org/10.1161/JAHA.122.028849
21. Nair A, Pillai AJ, Nair N. Cardiovascular changes in menopause. Curr Cardiol Rev 2021;17:e230421187681. DOI: https://doi.org/10.2174/1573403X16666201106141811
22. Camilleri G, Borg M, Brincat S, et al. The role of cytokines in cardiovascular disease in menopause. Climacteric 2012;15:524-30. DOI: https://doi.org/10.3109/13697137.2012.700743
23. Henderson NC, Sethi T. The regulation of inflammation by galectin-3. Immunol Rev 2009;230:160-71. DOI: https://doi.org/10.1111/j.1600-065X.2009.00794.x
How to Cite
Evaluating serum galectin-3 binding protein as a diagnostic and prognostic biomarker in pulmonary arterial hypertension: a comparative study. (2024). Global Cardiology, 2(4). https://doi.org/10.4081/cardio.2024.50
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Marc Atzenhoefer, Elizabeth Dille, Rebecca Steinke, Nicole Weigert, Keri Sabel, Kirsten Rasmussen, Bridging the gap between study outcomes and real-world results. Algorithm-driven management in a rural cardioMEMS population , Global Cardiology: Forthcoming
- Thomas Bernd Dschietzig, Guy Salama, Relaxin-2 for heart failure with preserved ejection fraction: a comment on the termination of a phase-II trial investigating the relaxin-2 analogue, LY3540378 , Global Cardiology: Vol. 2 No. 4 (2024)
- Petros Fountoulakis, Aikaterini Siama, Aimilianos Kalogeris, Marianthi Iliopoulou, Athanasios Tsoukas, Athanasios Manolis, Tricuspid valve fungal endocarditis in a patient with breast cancer and an implantable chemotherapy venous access port , Global Cardiology: Vol. 1 No. 1 (2023)
- Andrew J.S. Coats, Global Cardiology issue highlights , Global Cardiology: Vol. 2 No. 2 (2024)
- Muhammad Shahzeb Khan, Javed Butler, Laibah Arshad Khan, Markus S. Anker, Advanced cancer as a heart failure like syndrome due to cardiac wasting cardiomyopathy: facts and numbers , Global Cardiology: Vol. 2 No. 4 (2024)
- Anders Larsson, Bertil Wegmann, Toralph Ruge, Joakim Alfredsson, Carl Johan Östgren, Tomas Lindahl, Elevated endostatin is associated with hypertension treatment, elevated high sensitivity C-reactive protein, increased waist-hip ratio, and attenuated kidney function, but not with age, in a middle-aged population , Global Cardiology: Forthcoming
- Giuseppe M.C. Rosano, Clinical trial design, endpoints and regulatory considerations in heart failure , Global Cardiology: Vol. 2 No. 1 (2024)
- Giuseppe M.C. Rosano, Andrew J.S. Coats, Modulation of cardiac metabolism in heart failure , Global Cardiology: Vol. 2 No. 3 (2024)
- Ali A. Youssef, Shaima Al-Omani, Mustafa A. Alrefae, Ahmad Suliman, Reem Hassan, Omar Saleh, Zizi S. Khalifa, New left ventricular thrombus and embolic events in left ventricular dysfunction postmyocardial infarction , Global Cardiology: Vol. 2 No. 3 (2024)
- Muhammad Shahzeb Khan, Javed Butler, Tim Friede, Piotr Ponikowski, Stefan D. Anker, To clip or not to clip moderate-to-severe functional mitral regurgitation in patients with heart failure? , Global Cardiology: Vol. 2 No. 3 (2024)
You may also start an advanced similarity search for this article.
